WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

IMPACT OF COVID-19 ON DIABETIC PATIENTS

Shrutika Y. Desai* and Sushant P. Kokane

ABSTRACT

Diabetes patients who develop corona virus disease 2019 (COVID-19) are at risk of a serious course of illness and death. After the initial COVID-19 outbreak in China, due to poor prognosis in those with the infection, significant attention has been concentrated on people with diabetes. Original studies focused mainly on people with type 2 diabetes, but recent findings have shown that people with type 1 diabetes are also at risk of extreme COVID-19. Most frequently it has been reported that patients having Diabetes are infected with COVID-19.Information about the effects of COVID-19 in people with diabetes (PWD) is minimal but is still evolving. PWD tends to beat higher risk of more serious COVID 19 infection, although it is highly uncertain to equalize the risk. We were pleased to study briefly the general characteristics of the novel corona virus (SARS-CoV-2) to have a clear understanding of thecorona virus disease (COVID-19) in people with diabetes and its management. The natural course of COVID-19 in diabetes patients needs to be further studied and the human, geographical, and ethnic variations in disease prevalence and course need to be understood.

Keywords: COVID-19, SARS-CoV-2, Diabetes, Comorbidity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More